Latest News of BGNE
Here's Why BeiGene, Ltd. (BGNE) Rallied in Q3
By Yahoo! Finance |
1 month ago
Baird Asset Management's Chautauqua Capital Management released the Q3 2024 investor letter for the "Baird Chautauqua International and Global Growth Fund," showcasing strong performance in global equ...
Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)
By Yahoo! Finance |
3 months ago
BeiGene faces challenges in its growth due to competition and regulatory factors. Despite financial gains, net losses persist. With a robust product pipeline and global presence, the company aims for ...
When Will BeiGene, Ltd. (NASDAQ:BGNE) Become Profitable?
By Yahoo! Finance |
4 months ago
BeiGene, Ltd., a leading oncology company, is progressing towards profitability with a projected breakeven in 2025. Analysts anticipate a profit of US$222m in 2026, expecting a 60% annual growth rate....
-
Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
By Yahoo! Finance | 4 months agoJulia Wang, CFO of BeiGene Ltd, sold 899 shares at $155.66 each, owning 432,731 shares. The biotech company focuses on cancer treatments globally. Wang's recent sale raises interest due to insider beh...
-
BeiGene, Ltd. (NASDAQ:BGNE) Shares Could Be 47% Below Their Intrinsic Value Estimate
By Yahoo! Finance | 5 months agoThe intrinsic value of BeiGene, Ltd. (NASDAQ: BGNE) is estimated using the Discounted Cash Flow (DCF) model, resulting in a Total Equity Value of US$33b. This indicates the stock is currently underval...